Article Details
Retrieved on: 2020-12-17 13:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Enteris <b>BioPharma's</b> most advanced internal product candidate, Ovarest<sup>®</sup> (oral leuprolide tablet), is an oral peptide being developed for the treatment of ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here